8 citations,
April 2020 in “Journal of The American Academy of Dermatology” Bicalutamide may be a promising alternative treatment for female pattern hair loss.
29 citations,
May 1998 in “Bulletin of the American College of Nurse-Midwifery” The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.
March 2025 in “JAAD reviews.” This review assesses the efficacy and safety of bicalutamide, a nonsteroidal antiandrogen, for treating female pattern hair loss (FPHL) and other hair loss disorders. Analyzing 9 articles with 494 female patients, it found bicalutamide reduced hair loss severity by 17% to 28.9% in FPHL patients, especially effective in those with hyperandrogenic conditions like polycystic ovarian syndrome. However, its efficacy in fibrosing alopecia and central centrifugal cicatricial alopecia was limited. Adverse events occurred in 11.9% of patients. Bicalutamide shows promise as a treatment for FPHL, with efficacy comparable to or better than spironolactone, though more research is needed for other hair loss types.
September 2024 in “Journal of Cutaneous and Aesthetic Surgery” Bicalutamide may help treat female pattern hair loss.
research Skin
2 citations,
January 2011 in “Elsevier eBooks” Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.